RT @dhovekamp42: @MedigeneAG haven't you thought about 2nd RhuDex partnership lately? https://t.co/M1c4R2cT0Z https://t.co/2WyBrHDDSD
115 followers
3,957 followers
@MedigeneAG haven't you thought about 2nd RhuDex partnership lately? https://t.co/M1c4R2cT0Z https://t.co/2WyBrHDDSD
3,957 followers
Inhibition of B7-1 by RhuDex® Reduces Lipopolysaccharide-Mediated Inflammation in Human Atherosclerotic Lesions http://t.co/PNtEFBgQ1c
9,431 followers
Inhibition of B7-1 by RhuDex® Reduces Lipopolysaccharide-Mediated Inflammation in Human Atherosclerotic Lesions http://t.co/PNtEFBgQ1c
3,957 followers
Further option for Medigene: RhuDex® may be a useful therapy to modulate the inflammatory milieu in #atherosclerosis. http://t.co/BT85YTqkWM
3,957 followers
@FierceBiotech @JohnCFierce may be @Immunocore will point GSK to recent RhuDex® study results in atherosclerosis :) http://t.co/BT85YTqkWM